Clinical Trials Sponsored by Crown Laboratories, Inc.

Total 380 results

Crown Laboratories, Inc.

Completed

A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo

Vitiligo

United States
Crown Laboratories, Inc.

Completed

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subjects With Facial Acne Vulgaris, Ages 18 Through 45

Acne Vulgaris

United States
Crown Laboratories, Inc.

Completed

A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

Ichthyosis Vulgaris

United States
Crown Laboratories, Inc.

Completed

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging

Skin Aging

United States
Ranbaxy Laboratories Limited
Ohm Laboratories, Inc.

Completed

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

Healthy

United States
MedMira Laboratories Inc.

Withdrawn

Rapid Diagnostics for HIV and Hepatitis

HIV Infections | Hepatitis B Infections | Hepatitis C Infections

United States
Starkey Laboratories, Inc

Completed

Self Fitting Hearing Aid Clinical Investigation

Hearing Loss, Sensorineural

United States
Charleston Laboratories, Inc

Completed

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

Pain | Nausea | Vomiting | Migraine | Aura

United States
Concordia Laboratories Inc.

Terminated

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Hilar Cholangiocarcinoma

United States, Korea, Republic of, Canada, Switzerland, Germany
Aponia Laboratories, Inc.

Completed

Phase II Study of AP0302 5% Versus a Vehicle Comparator

Pain | Delayed Onset Muscle Soreness

United States
Charleston Laboratories, Inc

Completed

A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions

Healthy
Charleston Laboratories, Inc

Completed

Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain

Pain | Nausea | Vomiting

United States
Paddock Laboratories, Inc.

Completed

A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions

Healthy

United States
Scarless Laboratories, Inc.

Recruiting

Dose Regimen Study of SLI-F06 in Healthy Volunteers

Scar | Wound Healing

United States
Center Laboratories, Inc.

Completed

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

T2DM With Inadequate Glycemic Control

Taiwan, United States
Concordia Laboratories Inc.

Completed

Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

Non-small Cell Lung Cancer (NSCLC) | Lung Metastasis

United States, Canada
Concordia Laboratories Inc.

Completed

Safety of PDT-Photofrin® Prior to Lung Surgery

Lung Cancer | Lung Cancer Metastatic

United States
Charleston Laboratories, Inc

Completed

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

Pain | Nausea | Vomiting
Center Laboratories, Inc.

Terminated

R-Verapamil for the Prophylaxis of Episodic Cluster Headache

Episodic Cluster Headache

United Kingdom
Elite Laboratories, Inc

Completed

A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects

Withdrawal Symptoms

United States
Elite Laboratories, Inc

Completed

A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery

Pain

United States
Antigen Laboratories, Inc.

Completed

Phase 2 Study in Adults Sensitized to Cat

Allergy

United States
Dot Laboratories, Inc.

Recruiting

The EMPOWER Study: Endometriosis Diagnosis Using microRNA (EMPOWER)

Endometriosis

United States
Charleston Laboratories, Inc

Completed

A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV

Pain | Nausea | Vomiting

United States
Aponia Laboratories, Inc.

Completed

Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

Pain, Acute

United States
Starkey Laboratories, Inc

Completed

Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids

Hearing Loss | Hearing Loss, Sensorineural

United States
Ferndale Laboratories, Inc.

Completed

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Charleston Laboratories, Inc

Completed

A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip

Pain | Nausea | Vomiting

United States
MedMira Laboratories Inc.

Completed

Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

HIV Infections

United States
Antigen Laboratories, Inc.

Withdrawn

Phase 2 Study in Adults Sensitized to Short Ragweed

Allergic Rhinitis
Paddock Laboratories, Inc.

Completed

A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

Healthy

United States
Watson Laboratories, Inc.

Completed

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Acne Vulgaris
Ferndale Laboratories, Inc.

Completed

LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery (LMX-4)

Post-Operative Pain

United States
Rapid Laboratories Inc.

Unknown

Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)

HIV Infections

United States
Actavis Inc.
Watson Laboratories, Inc.

Completed

A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

BACTERIAL VAGINOSIS | Signs and Symptoms to be Evaluated and Recorded Include | Vaginal Discharge Color, Odor, and Consistency | Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe | Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe

United States, Dominican Republic, Puerto Rico
Actavis Inc.
Watson Laboratories, Inc.

Completed

Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea

Rosacea

United States
BioNumerik Pharmaceuticals, Inc.
Crown Bioscience

Completed

Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer

Ovarian Cancer

Poland, Russian Federation, Romania, Hungary, Lithuania
BioNumerik Pharmaceuticals, Inc.
Crown Bioscience

Completed

Study of Karenitecin (BNP1350) to Treat Malignant Melanoma

Melanoma | Neoplasm

United States
BioNumerik Pharmaceuticals, Inc.
Crown Bioscience

Completed

Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer

Carcinoma | Carcinoma, Non-Small-Cell Lung

United States
BioNumerik Pharmaceuticals, Inc.
Crown Bioscience

Completed

Study of Karenitecin (BNP1350) in Patients With Brain Tumors

Brain Neoplasms | Brain Tumors | Malignant Neoplasms, Brain

United States
Actavis Inc.
Watson Laboratories, Inc.

Completed

Clinical Equivalence Study of Mometasone Nasal Spray

Seasonal Allergic Rhinitis

United States
Laboratoires Bodycad Inc.

Terminated

Investigational Testing of Bodycad Unicompartmental Knee Prosthesis (UKS)

Osteoarthritis, Knee

Canada
Myriad Genetic Laboratories, Inc.

Recruiting

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

Prostate Cancer

United States
Heart Test Laboratories, Inc.

Active, not recruiting

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

Cardiac Disease

United States
Myriad Genetic Laboratories, Inc.

Terminated

Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6 (PROFUSE)

Colorectal Cancer, Metastatic

United States
Myriad Genetic Laboratories, Inc.

Completed

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing (URO-009Low)

Prostate Cancer

United States
Myriad Genetic Laboratories, Inc.

Terminated

Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006) (ONC006)

NSCLC | Lung Cancer | NSCLC Adenocarcinoma

United States
Myriad Genetic Laboratories, Inc.

Withdrawn

Endometriosis Biomarker Discovery Study (EMBARK)

Endometriosis | Chronic Pelvic Pain
Myriad Genetic Laboratories, Inc.

Completed

Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients (PROCEDE-2000)

Prostate Cancer

United States
Unigene Laboratories Inc.
GlaxoSmithKline

Completed

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women

Postmenopausal Osteoporosis

Denmark, Estonia

3

Subscribe